|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 139.46 USD | +0.30% |
|
+6.16% | +25.05% |
| 11.12. | GLOBE LIFE INC. : TD Cowen behält seine Kaufempfehlung bei | ZM |
| 17.11. | GLOBE LIFE INC. : Bewertung von Morgan Stanley kaufen | ZM |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 5.78 Mrd. | 18.53% | 24.06% | 21.7% | - | 1.77x | |
| 90.55 Mrd. | 16.18% | 17.49% | 21.59% | 1.72% | - | |
| 19.31 Mrd. | 35.39% | 40.13% | 16.75% | 2.31% | - | |
| 104 Mrd. | 5.46% | 5.47% | 46.03% | 0.89% | -2.07x | |
| 10.6 Mrd. | 43.41% | 49.59% | 17.2% | 1.3% | - | |
| 76.58 Mrd. | 3.23% | 7.1% | 3.8% | 0.27% | 114.75x | |
| 13.71 Mrd. | 2.06% | 2.13% | 15.13% | 0.57% | - | |
| 14.47 Mrd. | 11.32% | 18.41% | 7.43% | 0.76% | 1.84x | |
| 11.26 Mrd. | 1.88% | 1.95% | 11.75% | 0.57% | - | |
| 24.91 Mrd. | 3.39% | - | 9.3% | 1.17% | - | |
| 41.17 Mrd. | 2% | 2.76% | 3.7% | 0.28% | - | |
| 5.53 Mrd. | 2.51% | 2.82% | 10.34% | 0.39% | - | |
| 2.43 Mrd. | 42.05% | 53.94% | 11.77% | 0.88% | - | |
| 1.26 Mrd. | -35.71% | 83.04% | 21.84% | 0.43% | - | |
| 32.22 Mrd. | 3.37% | 11.13% | 10% | 0.52% | - | |
| 3.09 Mrd. | 15.23% | 29.58% | 31.9% | - | - | |
| 8.44 Mrd. | 16.33% | 24.71% | 21.33% | - | 0.36x | |
| Durchschnitt | 27.34 Mrd. | 10.98% | 23.39% | 16.56% | 0.86% | 23.33x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 50.89 Mrd. | 17.57% | 22.89% | 19.95% | 1.38% | 26.50x |
- Börse
- Aktien
- A2PP68 Aktie
- Sektor Globe Life Inc.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben